JP2009108023A - Hair grower - Google Patents
Hair grower Download PDFInfo
- Publication number
- JP2009108023A JP2009108023A JP2008132033A JP2008132033A JP2009108023A JP 2009108023 A JP2009108023 A JP 2009108023A JP 2008132033 A JP2008132033 A JP 2008132033A JP 2008132033 A JP2008132033 A JP 2008132033A JP 2009108023 A JP2009108023 A JP 2009108023A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- thermolysin
- degradation product
- soybean protein
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 127
- 108090001109 Thermolysin Proteins 0.000 claims abstract description 73
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 68
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 58
- 235000019410 glycyrrhizin Nutrition 0.000 claims abstract description 32
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims abstract description 28
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 21
- 229960004949 glycyrrhizic acid Drugs 0.000 claims abstract description 19
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960003720 enoxolone Drugs 0.000 claims abstract description 14
- 108010009355 microbial metalloproteinases Proteins 0.000 claims abstract description 10
- 239000007857 degradation product Substances 0.000 claims description 61
- 230000000694 effects Effects 0.000 claims description 34
- 230000003779 hair growth Effects 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 28
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- 238000009472 formulation Methods 0.000 claims description 21
- 239000006210 lotion Substances 0.000 claims description 19
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 18
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 18
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 18
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 18
- 239000006071 cream Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 210000004761 scalp Anatomy 0.000 claims description 11
- 230000001815 facial effect Effects 0.000 claims description 7
- 239000002453 shampoo Substances 0.000 claims description 7
- 210000004709 eyebrow Anatomy 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 230000002424 anti-apoptotic effect Effects 0.000 claims description 4
- 230000017531 blood circulation Effects 0.000 claims description 4
- 230000001256 tonic effect Effects 0.000 claims description 4
- 102000011782 Keratins Human genes 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 3
- 230000002280 anti-androgenic effect Effects 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 239000000051 antiandrogen Substances 0.000 claims description 3
- 239000000739 antihistaminic agent Substances 0.000 claims description 3
- 229940088597 hormone Drugs 0.000 claims description 3
- 239000005556 hormone Substances 0.000 claims description 3
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 3
- 239000003018 immunosuppressive agent Substances 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 210000002374 sebum Anatomy 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 3
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 230000001861 immunosuppressant effect Effects 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000000354 decomposition reaction Methods 0.000 abstract description 8
- 230000003450 growing effect Effects 0.000 abstract 2
- -1 alkali metal salts Chemical class 0.000 description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 33
- 239000000194 fatty acid Substances 0.000 description 31
- 235000014113 dietary fatty acids Nutrition 0.000 description 30
- 229930195729 fatty acid Natural products 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 28
- 201000004384 Alopecia Diseases 0.000 description 21
- 239000008213 purified water Substances 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 19
- 238000000034 method Methods 0.000 description 18
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 18
- 239000000284 extract Substances 0.000 description 16
- 210000003780 hair follicle Anatomy 0.000 description 16
- 238000007796 conventional method Methods 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- 244000068988 Glycine max Species 0.000 description 13
- 231100000360 alopecia Toxicity 0.000 description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 229940001941 soy protein Drugs 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 9
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 9
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 9
- 229960002216 methylparaben Drugs 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 239000002280 amphoteric surfactant Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000031774 hair cycle Effects 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 108091005804 Peptidases Proteins 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 150000005215 alkyl ethers Chemical class 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000002481 ethanol extraction Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 206010068168 androgenetic alopecia Diseases 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 210000002919 epithelial cell Anatomy 0.000 description 4
- 210000000720 eyelash Anatomy 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960002449 glycine Drugs 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920001451 polypropylene glycol Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000017854 proteolysis Effects 0.000 description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 241000193389 Bacillus thermoproteolyticus Species 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 235000007862 Capsicum baccatum Nutrition 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 235000010724 Wisteria floribunda Nutrition 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000001728 capsicum frutescens Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 229930007845 β-thujaplicin Natural products 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- PHEDXBVPIONUQT-BJBOKCJXSA-N 12-Tetradecanoylphorbol 13-acetate Natural products O=C(O[C@H]1[C@@H](C)[C@@]2(O)[C@H]3[C@@](O)(C(=O)C(C)=C3)CC(CO)=C[C@H]2[C@H]2C(C)(C)[C@]12OC(=O)C)CCCCCCCCCCCCC PHEDXBVPIONUQT-BJBOKCJXSA-N 0.000 description 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920000855 Fucoidan Polymers 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229960001716 benzalkonium Drugs 0.000 description 2
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 2
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 229960002568 ethinylestradiol Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 210000004919 hair shaft Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 2
- 210000002488 outer root sheath cell Anatomy 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 229960001755 resorcinol Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- PMUWWDBIGFMHAW-SJORKVTESA-N (2r,3r)-3-hydroxy-3-methyl-2-(4-methylphenyl)-2h-chromen-4-one Chemical compound C1=CC(C)=CC=C1[C@@H]1[C@](O)(C)C(=O)C2=CC=CC=C2O1 PMUWWDBIGFMHAW-SJORKVTESA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- FCAXDVKLWVSHGT-KVVVOXFISA-N (z)-docos-13-enoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O FCAXDVKLWVSHGT-KVVVOXFISA-N 0.000 description 1
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- XJFPXLWGZWAWRQ-UHFFFAOYSA-N 2-[[2-[[2-[[2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetate Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(O)=O XJFPXLWGZWAWRQ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- SGPMPZKXUXPIBJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC Chemical compound C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC SGPMPZKXUXPIBJ-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000723438 Cercidiphyllum japonicum Species 0.000 description 1
- 244000237791 Chionanthus virginicus Species 0.000 description 1
- 235000015256 Chionanthus virginicus Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000267823 Hydrangea macrophylla Species 0.000 description 1
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 208000026709 Liddle syndrome Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 206010037113 Pseudoaldosteronism Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 229960003872 benzethonium Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 210000000185 follicular epithelial cell Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940078498 peg-5 glyceryl stearate Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 229910000338 selenium disulfide Inorganic materials 0.000 description 1
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N selenium sulfide Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- RUTSRVMUIGMTHJ-UHFFFAOYSA-M sodium;tetradec-1-ene-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCC=CS([O-])(=O)=O RUTSRVMUIGMTHJ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、育毛剤、さらに詳しくはグリチルリチン酸類と、ダイズタンパク質のプロテアーゼ分解物とを含有する育毛剤に関する。本発明はまた、当該育毛剤を含有する製剤に関する。 The present invention relates to a hair restorer, and more particularly to a hair restorer containing glycyrrhizic acids and a protease degradation product of soybean protein. The present invention also relates to a preparation containing the hair restorer.
近年、老若男女を問わず毛髪への関心は強くなっている。特に美容上、頭髪量の減少は、精神的なコンプレックスを生むことが多く、QOL(=Quality of Life)の悪化を招きやすい。 In recent years, interest in hair has become stronger regardless of age or sex. Particularly in terms of beauty, a reduction in the amount of hair often produces a mental complex and tends to cause a deterioration in QOL (= Quality of Life).
ヒトを含む動物の毛組織は、ヘアサイクル(毛周期ともいう)と呼ばれる周期をもって絶えず変化している。このヘアサイクルを司り、各ステージの移行に深く影響を与えるのは、毛組織の中央底部に位置する間葉系組織由来の毛乳頭細胞とも言われている。また近年この毛乳頭細胞は、毛包の大きさに影響を与え、ひいては、その毛包から生えてくる毛の太さに影響を与えることも知られている(非特許文献1等)。 The hair tissue of animals including humans is constantly changing with a cycle called a hair cycle (also called a hair cycle). It is said that the hair papilla cells derived from the mesenchymal tissue located at the center bottom of the hair tissue that govern this hair cycle and deeply influence the transition of each stage. In recent years, it has also been known that the dermal papilla cell affects the size of the hair follicle and, consequently, the thickness of the hair that grows from the hair follicle (Non-patent Document 1, etc.).
また毛組織では、かかる毛乳頭細胞を取り囲むようにして、毛包上皮細胞が存在する。毛包上皮細胞のうち毛乳頭細胞と接する部分にあるのが毛母細胞であり、ヘアサイクルの成長期にはこの毛母細胞が増殖して毛が作り出される。さらに毛包上皮細胞のうち毛の周囲を取り巻く外毛根鞘細胞は、毛母へ新しい細胞を供給したり、ヘアサイクルを円滑に進めるうえで重要な役割を担ったり、休止期毛がすぐに抜け落ちてしまわないように留めておく機能等があることが知られている。 In the hair tissue, follicular epithelial cells exist so as to surround the dermal papilla cells. Hair follicle epithelial cells are in contact with hair papilla cells and are hair matrix cells. During the growth phase of the hair cycle, the hair matrix cells proliferate to produce hair. In addition, the outer root sheath cells surrounding the hair of the hair follicle epithelial cells play an important role in supplying new cells to the hair matrix and promoting the hair cycle smoothly. It is known that there is a function to keep it from falling out.
ヘアサイクルでは、成長期が満ちると、毛母細胞にアポトーシスが誘導される。そして、ヘアサイクルは退行期へ、続いて休止期へと移行し、毛の成長は停止する。休止期においては、毛乳頭細胞は不明瞭になり、毛包は短く萎縮して皮膚の中で浅く位置する。そして一定期間経過後、再び毛母細胞の増殖が起こり、古い毛が抜け、新しい毛が生える早期成長期となる。そして時間が経つにつれ、毛包は大きく長くなって皮膚中深く位置する後期成長期毛包となる。健全な毛組織ではこのサイクルを繰り返して毛を作り出している。 In the hair cycle, when the growth phase is full, apoptosis is induced in the hair matrix cells. The hair cycle then proceeds to the regression phase and then to the resting phase, and hair growth stops. In the resting phase, the dermal papilla cells become obscure and the hair follicles are short atrophied and located shallow in the skin. After a certain period of time, the hair matrix cells proliferate again, leading to an early growth period in which old hair is lost and new hair grows. As time goes on, the hair follicles become larger and longer and become late growth hair follicles located deep in the skin. In healthy hair tissue, this cycle is repeated to produce hair.
一般には、毛の太さは成長期に生育する毛包の大きさにほぼ比例し、毛の長さは成長期の期間の長さに比例して決定されると考えられている。健康な毛髪の約90%以上は成長期にあると言われており、この時期に毛母細胞が盛んに分裂・増殖を繰り返して、毛は太く長く成長する。一方、この時期が短くなると、毛は細いまま十分に成長できず薄毛の原因となる。そして毛が十分に成長する前に抜け落ちてゆき、毛はどんどん細くなって産毛のような状態となり、また徐々に成長期に移行しない毛包も増えて、最終的に脱毛状態に至ることが知られている。このように、「脱毛症」は、育毛や発毛の阻害と深く関連して発症している。 In general, it is considered that the thickness of the hair is approximately proportional to the size of the hair follicle that grows in the growing period, and the length of the hair is determined in proportion to the length of the growing period. About 90% or more of healthy hair is said to be in the growth phase, and during this period, the hair matrix cells actively divide and proliferate, and the hair grows thick and long. On the other hand, if this period is shortened, the hairs are thin and cannot grow sufficiently, causing thin hairs. It is known that the hair falls off before it grows sufficiently, the hair becomes thinner and becomes like a vellus hair, and the number of hair follicles that do not gradually shift to the growth stage gradually increases, eventually leading to a hair loss state. It has been. Thus, “alopecia” develops in close relation to hair growth and inhibition of hair growth.
最も多く見られる脱毛症は男性ホルモン性脱毛症(壮年性脱毛症)であり、男性の約半数(男性型脱毛症)、女性の10-20%(女性型脱毛症)が男性ホルモン性脱毛症にかかる。遺伝的素因が大きく係わっており、男性では典型的な抜け毛から完全又は部分的な脱毛症を来すことが多いが、女性では、毛が全体に薄くなるのが一般的である。その他、肉体的・精神的ストレスが原因で起こる中毒性脱毛症、急激な体重減や重い病気、手術、癌(がん)の化学療法薬等によっても脱毛症は誘発される。さらに、円形脱毛症、瘢痕性脱毛症などが知られている。 The most common alopecia is androgenetic alopecia (mature alopecia), about half of men (male pattern baldness) and 10-20% of women (female pattern baldness) androgenetic alopecia It takes. Genetic predisposition is largely involved, and in men it is common to have complete or partial alopecia from typical hair loss, but in women it is common for hair to be thin overall. Alopecia is also induced by toxic alopecia caused by physical and mental stress, rapid weight loss and severe illness, surgery, and cancer (cancer) chemotherapeutic drugs. Furthermore, alopecia areata, scarring alopecia and the like are known.
これらの薄毛・脱毛状態を予防又は改善するために、従来から様々な育毛剤が開発されている。例えば、毛包周辺組織の新陳代謝を促進したり、毛包周辺組織の血流を増大させて毛母細胞などの毛包上皮細胞の増殖を促進するために、プラセンタエキス、ニンジンエキス、センブリエキス、パントテン酸、ビタミンE、トウガラシチンキ、ニコチン酸誘導体、ミノキシジルや、グリチルリチン酸、グリチルレチン酸、又はこれらの塩などが育毛剤に用いられている。また、グリチルリチン酸、グリチルレチン酸、若しくはこれらの塩の育毛効果が、植物抽出物などや薬剤との併用により、増強されることも報告されている(特許文献1、2)。 In order to prevent or improve these thinning / hair loss states, various hair growth agents have been developed conventionally. For example, in order to promote metabolism of tissues around hair follicles or increase blood flow in tissues around hair follicles to promote proliferation of hair follicle epithelial cells such as hair matrix cells, placenta extract, carrot extract, assembly extract, Pantothenic acid, vitamin E, red pepper tincture, nicotinic acid derivative, minoxidil, glycyrrhizic acid, glycyrrhetinic acid, or salts thereof are used as hair restorers. It has also been reported that the hair-growth effect of glycyrrhizic acid, glycyrrhetinic acid, or a salt thereof is enhanced by the combined use with a plant extract or a drug (Patent Documents 1 and 2).
上記の通り、脱毛や発毛、育毛阻害の原因は様々であり、脱毛症は、健常人のみならず何らかの疾患を罹患している患者にも発現する。一方、育毛剤は、通常、日常的に継続使用されることが多い。このような観点から、優れた育毛効果と高い安全性を兼ね備えた育毛剤の開発が強く求められている。しかしながら、従来の育毛剤は必ずしもこのような需要に応えるものではなかった。例えば、グリチルリチン酸は脱毛症等に適用されるが、偽アルドステロン症を引き起こす恐れがあると言われており、その育毛効果が安全かつ有効に発揮されるような処方の開発が強く望まれている。 As described above, there are various causes of hair loss, hair growth and hair growth inhibition, and alopecia is manifested not only in healthy individuals but also in patients suffering from some kind of disease. On the other hand, hair growth agents are usually used continuously on a daily basis. From such a point of view, there is a strong demand for the development of a hair restoration agent that has both an excellent hair restoration effect and high safety. However, the conventional hair restorer does not necessarily meet such demand. For example, although glycyrrhizic acid is applied to alopecia and the like, it is said that it may cause pseudoaldosteronism, and there is a strong demand for the development of a formulation that exhibits its hair-restoring effect safely and effectively. .
ダイズタンパク質のプロテアーゼ分解物については、食品、医薬品、化粧品等様々な分野でその応用が試みられている。例えば、ダイズタンパク質のサーモリシン分解物がコラーゲン及びヒアルロン酸からなる群から選択される物質の産生を促進するとして、コラーゲン及び/又はヒアルロン酸量の低下に起因する疾患や身体状態等の予防、治療又は改善等における用途が報告されている(特許文献3)。しかしながら、該特許文献3には、ダイズタンパク質のサーモリシン分解物の育毛効果又は育毛活性については一切記載されていない。 Application of protease degradation products of soy protein has been attempted in various fields such as foods, pharmaceuticals, and cosmetics. For example, as the thermolysin degradation product of soybean protein promotes the production of a substance selected from the group consisting of collagen and hyaluronic acid, prevention, treatment, or the like of diseases and physical conditions caused by a decrease in the amount of collagen and / or hyaluronic acid, or The use in improvement etc. is reported (patent document 3). However, Patent Document 3 does not describe any hair-growth effect or hair-growth activity of the thermolysin degradation product of soybean protein.
本発明は、広範な対象に対して安全に使用することができる、育毛効果と安全性が高い育毛剤を提供することを目的としている。
具体的には、本発明の目的は、グリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩の育毛効果が向上されており、より安全性の高い育毛剤を提供することにある。また、本発明の目的は、当該育毛剤を含有する製剤を提供することにある。
An object of the present invention is to provide a hair-restoring agent that can be safely used for a wide range of subjects and has high hair-restoring effect and high safety.
Specifically, an object of the present invention is to provide a safer hair restoration agent in which the hair restoration effect of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof is improved. Another object of the present invention is to provide a preparation containing the hair restorer.
本発明者らは、前記課題を解決するために鋭意検討した結果、ダイズタンパク質をサーモリシンで分解して得られる分解産物がグリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩の育毛効果を向上させることを見出し、本発明を完成するに至った。 As a result of intensive investigations to solve the above problems, the present inventors have improved the hair-growth effect of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof obtained by decomposing soybean protein with thermolysin. And the present invention has been completed.
従って、本発明は以下を提供する。
(1) 以下の成分:
(A)グリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩からなる群より選択される1種又は2種以上、及び
(B)ダイズタンパク質のサーモリシン分解物又はダイズタンパク質のサーモリシン様プロテアーゼ分解物であって、サーモリシン分解物と同等の活性を有する産物
を含有する育毛剤。
(2) 成分(A)が、グリチルリチン酸ジカリウムである(1)記載の育毛剤。
(3) 成分(B)が、ダイズタンパク質のサーモリシン分解物である(1)又は(2)に記載の育毛剤。
(4) 成分(A)の配合量が0.01〜99重量%であり、成分(B)の配合量が0.0001〜99重量%である、(1)〜(3)のいずれかに記載の育毛剤。
(5) 成分(B)の平均分子量が300〜10000である、(1)〜(4)のいずれかに記載の育毛剤。
(6) さらに、成分(C)として細胞賦活剤、血行促進剤、抗男性ホルモン剤、皮脂分泌抑制剤、免疫抑制剤、抗ヒスタミン剤、殺菌消毒剤、局所刺激剤、角質軟化剤、消炎剤、及び抗アポトーシス剤からなる群より選択される1種又は2種以上をも含有する、(1)〜(5)のいずれかに記載の育毛剤。
(7) (1)〜(6)のいずれか1つに記載の育毛剤を含有する、製剤。
(8) 医薬品、医薬部外品、化粧品、食品である、(7)記載の製剤。
(9) シャンプー、ヘアコンディショナー、頭皮用ローション、頭皮用クリーム、ヘアトニック、全身クリーム、全身ローション、顔用クリーム、顔用ローション、アイライナー、アイブローである、(7)または(8)のいずれかに記載の製剤。
Accordingly, the present invention provides the following.
(1) The following ingredients:
(A) One or more selected from the group consisting of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof, and (B) a thermolysin degradation product of soybean protein or a thermolysin-like protease degradation product of soybean protein A hair restorer containing a product having an activity equivalent to that of a thermolysin degradation product.
(2) The hair restorer according to (1), wherein the component (A) is dipotassium glycyrrhizinate.
(3) The hair restorer according to (1) or (2), wherein the component (B) is a thermolysin degradation product of soybean protein.
(4) The amount of component (A) is 0.01 to 99% by weight, and the amount of component (B) is 0.0001 to 99% by weight, according to any one of (1) to (3) The hair restorer described.
(5) The hair restorer according to any one of (1) to (4), wherein the component (B) has an average molecular weight of 300 to 10,000.
(6) Furthermore, as a component (C), a cell activator, a blood circulation promoter, an anti-androgen hormone agent, a sebum secretion inhibitor, an immunosuppressant, an antihistamine, a bactericidal disinfectant, a local stimulant, a keratin softener, an anti-inflammatory agent, and The hair restorer according to any one of (1) to (5), which also contains one or more selected from the group consisting of anti-apoptotic agents.
(7) A preparation comprising the hair-restoring agent according to any one of (1) to (6).
(8) The preparation according to (7), which is a pharmaceutical, a quasi-drug, a cosmetic, or a food.
(9) Shampoo, hair conditioner, scalp lotion, scalp cream, hair tonic, whole body cream, whole body lotion, facial cream, facial lotion, eyeliner, eyebrow, either (7) or (8) The preparation described in 1.
本発明により、顕著に高い育毛効果を有する新規で有用な育毛剤が提供される。本発明の育毛剤は、ダイズタンパク質のサーモリシン又はサーモリシン様プロテアーゼによる分解物を配合することによってグリチルリチン酸等の育毛効果が増強又は向上されているので、優れた育毛効果を有すると同時に安全性が高く、広範な使用者が安心して継続的に使用することができる。本発明で用いるダイズタンパク質の酵素分解物は食品添加物等として幅広く利用されており、生体に対して安全である、という点でも好ましい素材である。 According to the present invention, a new and useful hair restoring agent having a significantly high hair restoring effect is provided. The hair-growth agent of the present invention has an enhanced hair-growth effect such as glycyrrhizic acid by blending a degradation product of soybean protein with thermolysin or thermolysin-like protease. Wide range of users can use it with peace of mind. The enzyme degradation product of soybean protein used in the present invention is widely used as a food additive and the like, and is also a preferable material in that it is safe for a living body.
以下、本発明を詳細に説明する。本明細書の全体にわたって、単数形の表現は、特に他に言及しない限り、その複数形の概念をも含むことが理解されるべきである。また、本明細書中において使用される用語は、特に他に言及しない限り、当該分野で通常用いられる意味で用いられていることが理解されるべきである。 Hereinafter, the present invention will be described in detail. Throughout this specification, it should be understood that expression in the singular also includes the concept of the plural unless specifically stated otherwise. In addition, it is to be understood that the terms used in the present specification are used in the meaning normally used in the art unless otherwise specified.
本発明の育毛剤は、(A)グリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩からなる群より選択される1種又は2種以上と、(B)ダイズタンパク質のサーモリシン分解物又はダイズタンパク質のサーモリシン様プロテアーゼ分解物であって、サーモリシン分解物と同等の活性を有する産物、とを含有することを特徴とする。 The hair restorer of the present invention comprises (A) one or more selected from the group consisting of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof, and (B) a thermolysin degradation product of soybean protein or soybean It is a thermolysin-like protease degradation product of a protein, and a product having an activity equivalent to that of the thermolysin degradation product.
本発明の育毛剤は、脱毛症の多くを占める壮年性脱毛症を初め、様々な脱毛症に好適に使用できる。具体的には、ダイズタンパク質のサーモリシン分解物をグリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩からなる群より選択される1種又は2種以上[以下、「グリチルリチン酸類」とも称する]と併用して、グリチルリチン酸類の育毛効果を増強する、という意味から、グリチルリチン酸類の適用対象である脱毛症(例えば壮年性脱毛症)に対して、より好適に使用できるが、それらに限定されない。 The hair-restoring agent of the present invention can be suitably used for various alopecia, including the adolescent alopecia that accounts for most alopecia. Specifically, the thermolysin degradation product of soybean protein is one or more selected from the group consisting of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof [hereinafter also referred to as “glycyrrhizic acids”] From the viewpoint of enhancing the hair-growth effect of glycyrrhizic acids when used in combination, it can be more suitably used for alopecia (for example, alopecia areata) to which glycyrrhizic acids are applied, but is not limited thereto.
本発明の育毛剤に用いるグリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩からなる群より選択される1種又は2種以上は、医薬品、医薬部外品で通常用いられているものであれば特に制限されず用いることができる。
グリチルリチン酸類は、公知の方法により合成してもよく、或いは市販品として入手することもできる。
One or more selected from the group consisting of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof used in the hair restorer of the present invention are those usually used in pharmaceuticals and quasi drugs. If there is no particular limitation, it can be used.
Glycyrrhizic acids can be synthesized by known methods or can be obtained as commercial products.
本発明の育毛剤に用いる、グリチルリチン酸又はグリチルレチン酸の誘導体としては、例えば、ステアリル酸等の脂肪酸とのエステル誘導体が挙げられる。 Examples of derivatives of glycyrrhizic acid or glycyrrhetinic acid used in the hair restorer of the present invention include ester derivatives with fatty acids such as stearyl acid.
本発明の育毛剤に用いる、グリチルリチン酸又はグリチルレチン酸の塩としては、ナトリウム、カリウム等のアルカリ金属塩や、アンモニウム塩等が挙げられる。 Examples of the salt of glycyrrhizic acid or glycyrrhetinic acid used in the hair restorer of the present invention include alkali metal salts such as sodium and potassium, ammonium salts and the like.
本発明の育毛剤に用いるグリチルリチン酸類の具体例としては、例えば、グリチルリチン酸、グリチルリチン酸モノアンモニウム、グリチルリチン酸ステアリル、グリチルリチン酸ジカリウム、グリチルレチン酸、グリチルレチン酸ステアリル等が挙げられる。
また、グリチルリチン酸類は、これらを含有するカンゾウ等の生薬や生薬末、生薬エキスとして本発明の育毛剤に配合されていてもよい。
グリチルリチン酸類としては、好ましくはグリチルリチン酸の塩であり、より好ましくはグリチルリチン酸のアルカリ金属塩であり、特に好ましくはグリチルリチン酸ジカリウムである。
Specific examples of glycyrrhizic acids used in the hair restorer of the present invention include glycyrrhizic acid, monoammonium glycyrrhizinate, stearyl glycyrrhizinate, dipotassium glycyrrhizinate, glycyrrhetinic acid, stearyl glycyrrhetinate.
Moreover, glycyrrhizic acids may be blended in the hair restorer of the present invention as herbal medicines such as licorice, herbal powders or herbal extracts containing them.
The glycyrrhizic acid is preferably a salt of glycyrrhizic acid, more preferably an alkali metal salt of glycyrrhizic acid, and particularly preferably dipotassium glycyrrhizinate.
本発明の育毛剤に配合されるグリチルリチン酸類の配合量は、特に制限されないが、本発明の育毛剤全量に対して、通常0.01〜99重量%、好ましくは0.05〜50重量%、さらに好ましくは0.1〜10重量%である。 The amount of glycyrrhizic acid compounded in the hair restorer of the present invention is not particularly limited, but is usually 0.01 to 99% by weight, preferably 0.05 to 50% by weight, based on the total amount of the hair restorer of the present invention. More preferably, it is 0.1 to 10% by weight.
「ダイズタンパク質のサーモリシン分解物」とは、ダイズタンパク質を耐熱性のプロテアーゼの一種であるサーモリシンにより分解して得られる産物(分解産物)である。本発明に使用するダイズタンパク質のサーモリシン分解物は、例えば、特許文献3に記載の方法に従って製造することができる。 “Thermolysin degradation product of soybean protein” is a product (degradation product) obtained by degrading soybean protein with thermolysin, which is a kind of heat-resistant protease. The thermolysin degradation product of soybean protein used in the present invention can be produced, for example, according to the method described in Patent Document 3.
原料であるダイズタンパク質は、マメ科の一年草植物であるダイズ(Glycin max)由来のタンパク質であれば、品種や部位は特に限定されない。部位としては、ダイズ植物そのものやダイズ植物の種子そのもの、或いは該植物や該種子の破砕物又は粉砕物等を用いてもよいが、好ましくはダイズ植物中の全成分からタンパク質成分を分離・精製したもの、より好ましくは、ダイズ植物の種子中の全成分からタンパク質成分を分離・精製したものが用いられる。このように分離・精製して得られたダイズタンパク質は、それをサーモリシンで分解して得られる産物がグリチルリチン酸類の育毛効果を増強する限り、ダイズ植物またはダイズ植物の種子中に含まれる実質的に全種類のタンパク質を含むものでもよく、一部の種類のタンパク質を含むものであってもよい。しかし、入手の容易性等を考慮して、種子が好ましい。 As long as the soybean protein as a raw material is a protein derived from soybean (Glycin max), which is an annual plant of the leguminous family, the variety and part thereof are not particularly limited. The site may be soybean plant itself, soybean plant seed itself, or the plant or a crushed or crushed product of the seed. Preferably, protein components are separated and purified from all components in the soybean plant. More preferably, a product obtained by separating and purifying protein components from all components in the seeds of soybean plants is used. Soy protein obtained by separation and purification as described above is substantially contained in soybean plant or soybean plant seeds as long as the product obtained by decomposing it with thermolysin enhances the hair growth effect of glycyrrhizic acids. All types of proteins may be included, or some types of proteins may be included. However, in view of availability and the like, seeds are preferable.
なお本明細書において、ダイズ植物の種子とは、ダイズ種子と通常呼ばれる構造物全体を指すのみならず、例えば、脱皮ダイズ種子、脱脂ダイズ種子(粉末状のもの等)、ダイズ種子全体より得られる雪花菜(オカラ)、豆乳等であっても良い。 In the present specification, the seeds of soybean plants not only refer to the whole structure commonly referred to as soybean seeds, but are obtained from, for example, dehulled soybean seeds, defatted soybean seeds (powdered ones, etc.) and whole soybean seeds. Snow flowers, soy milk, etc. may be used.
ダイズタンパク質としては、市販品も好適に用いることができ、例えば、日清コスモフーズ(株)、ADMファーイースト(株)、昭和産業(株)、不二製油(株)、(株)光洋商会などの製造業者または供給業者から容易に入手可能である。 As the soybean protein, commercially available products can also be suitably used. For example, Nisshin Cosmo Foods Co., Ltd., ADM Far East Co., Ltd., Showa Sangyo Co., Ltd., Fuji Oil Co., Ltd., Koyo Shokai Co., Ltd. Readily available from manufacturers or suppliers.
本発明に用いられるサーモリシン(EC3.4.24.27)は、耐熱性菌であるBacillus thermoproteolyticusによって生産される耐熱性のプロテアーゼとして周知であり、その遺伝子もクローニングされている。サーモリシンは一般に、大きな側鎖をもった疎水性のアミノ酸残基(例えば、イソロイシン、ロイシン、バリン、フェニルアラニン、メチオニン、アラニンなど)のアミノ基側のペプチド結合を切断することが知られている。本発明には、野生型、組換型のいずれのサーモリシンを用いてもよい。また、市販品を好適に用いることもでき、例えば、大和化成(株)などの製造業者から容易に入手可能である。 Thermolysin (EC3.4.24.27) used in the present invention is well known as a heat-resistant protease produced by Bacillus thermoproteolyticus, which is a heat-resistant bacterium, and its gene has also been cloned. Thermolysin is generally known to cleave peptide bonds on the amino group side of hydrophobic amino acid residues having large side chains (for example, isoleucine, leucine, valine, phenylalanine, methionine, alanine, etc.). In the present invention, either wild type or recombinant thermolysin may be used. Moreover, a commercial item can also be used suitably, for example, it can obtain easily from manufacturers, such as Yamato Kasei Co., Ltd.
「サーモリシン様プロテアーゼ」とは、サーモリシンと酵素化学的、物理化学的な性質が類似している酵素、具体的には切断特性、切断配列特異性などが類似しているプロテアーゼを意味する。そのようなプロテアーゼとして、微生物が産生する中性金属プロテアーゼや、サーモリシンのアミノ酸変異体が挙げられる。サーモリシンの変異体は、例えば、特表平11-501501号公報に記載の方法を参照して製造することができる。
選択したサーモリシン様プロテアーゼを、該酵素に適した反応条件下でダイズタンパク質に適用し、得られたダイズタンパク質分解物の育毛促進活性を後述の実施例に記載の方法で試験することにより、育毛促進活性を有するサーモリシン様プロテアーゼのダイズタンパク質分解物を得ることができる。
“Thermolysin-like protease” means an enzyme similar in thermochemical and physicochemical properties to thermolysin, specifically a protease similar in cleavage characteristics, cleavage sequence specificity, and the like. Examples of such proteases include neutral metalloproteases produced by microorganisms and amino acid variants of thermolysin. A thermolysin variant can be produced, for example, with reference to the method described in JP-T-11-501501.
The selected thermolysin-like protease is applied to soybean protein under reaction conditions suitable for the enzyme, and the hair growth promoting activity of the resulting soybean protein degradation product is tested by the method described in the examples below, thereby promoting hair growth. A soybean protein degradation product of thermolysin-like protease having activity can be obtained.
以下、サーモリシンを例に挙げて説明するが、サーモリシン様プロテアーゼを用いる場合は、該酵素に適した条件下で同様にダイズタンパク質を処理することで、目的の分解物を得ることができる。
サーモリシン分解物は、適切な反応条件下、常法に従ってダイズタンパク質をサーモリシンで処理することによって製造することができる。例えば、市販のサーモリシンの場合には、使用説明書に従って反応を行う。具体的な例として、水などの溶媒に、ダイズタンパク質濃度が、一般的には0.1〜30%(w/v)、好ましくは1〜10%(w/v)程度となるようにダイズタンパク質又はダイズタンパク質を含む原料を懸濁し、この懸濁液に、一般的には0.001〜3%(w/v)、好ましくは0.01〜0.125%(w/v)程度となるようにサーモリシンを加え、分解反応を行う。通常、30〜80℃、好ましくは40〜70℃、より好ましくは50〜60℃の反応温度で、2〜30時間、好ましくは3〜24時間、より好ましくは10〜20時間、さらに好ましくは12〜18時間反応させると、適当に断片化されたダイズタンパク分解物が得られる。反応液のpHとしては、サーモリシンの至適pH付近であることが好ましく、例えば7.0〜8.5付近であることが好ましい。
Hereinafter, thermolysin will be described as an example. When thermolysin-like protease is used, the desired degradation product can be obtained by treating soybean protein in the same manner under conditions suitable for the enzyme.
The thermolysin degradation product can be produced by treating soybean protein with thermolysin according to a conventional method under appropriate reaction conditions. For example, in the case of commercially available thermolysin, the reaction is performed according to the instruction manual. As a specific example, soybean protein concentration in a solvent such as water is generally 0.1 to 30% (w / v), preferably 1 to 10% (w / v). A raw material containing protein or soybean protein is suspended, and the suspension generally has a concentration of about 0.001 to 3% (w / v), preferably about 0.01 to 0.125% (w / v). Add thermolysin so that the reaction proceeds. Usually, at a reaction temperature of 30 to 80 ° C., preferably 40 to 70 ° C., more preferably 50 to 60 ° C., 2 to 30 hours, preferably 3 to 24 hours, more preferably 10 to 20 hours, still more preferably 12 When reacted for ˜18 hours, an appropriately fragmented soybean protein degradation product is obtained. The pH of the reaction solution is preferably near the optimum pH of thermolysin, and is preferably around 7.0 to 8.5, for example.
反応の停止手段についても、特に制限はなく、加熱処理等、公知の手段を用いることができる。例えば、上記反応物を80〜100℃程度の温度で3〜20分間、好ましくは5〜15分間、加熱処理することにより、反応物中に含まれるサーモリシンを失活させる。加熱処理としては、85℃で15分間の加熱処理や100℃で5分間の加熱処理などが挙げられる。 The reaction stopping means is not particularly limited, and known means such as heat treatment can be used. For example, the thermolysin contained in the reaction product is deactivated by heat-treating the reaction product at a temperature of about 80 to 100 ° C. for 3 to 20 minutes, preferably 5 to 15 minutes. Examples of the heat treatment include a heat treatment at 85 ° C. for 15 minutes and a heat treatment at 100 ° C. for 5 minutes.
上記のような分解反応により得られるサーモリシン分解物は、必要に応じて、当業者に公知の任意の方法によりさらに処理してもよい。例えば、ろ過助剤等を使用したろ過等の処理により、該分解物中の大きな固体粒子を取り除くことが好ましい。ろ過条件等は、特に制限されず、技術常識に従い、目的に応じて当業者が適宜選択することができる。また、ろ紙が目詰まりを起こしやすい場合等には、ろ過助剤等を用いることが好ましい。 The thermolysin degradation product obtained by the above degradation reaction may be further processed by any method known to those skilled in the art, if necessary. For example, it is preferable to remove large solid particles in the decomposition product by a treatment such as filtration using a filter aid or the like. Filtration conditions and the like are not particularly limited, and can be appropriately selected by those skilled in the art according to technical common sense and according to the purpose. Further, when the filter paper is likely to be clogged, it is preferable to use a filter aid or the like.
また、前記分解物を減圧濃縮し、次いで凍結乾燥することにより、粉末化することもできる。減圧濃縮および凍結乾燥の際に使用される条件や機器類は、特に制限されず、技術常識に従って当業者が適宜選択することができる。このようにして粉末化された分解物は、そのまま又は水などの溶媒に溶解して使用する。 Further, the decomposition product can be pulverized by concentrating under reduced pressure and then freeze-drying. The conditions and equipment used for concentration under reduced pressure and lyophilization are not particularly limited, and can be appropriately selected by those skilled in the art according to common technical knowledge. The decomposition product pulverized in this way is used as it is or after being dissolved in a solvent such as water.
本発明に使用するサーモリシンによるダイズタンパク質分解物は、ダイズタンパク質のサーモリシンによる分解反応で得られる多種多様なペプチドを実質的に全て含んだ状態であってもよいし、又は、そのような多種多様なペプチドを、本発明の育毛効果の有無を指標として、公知の方法でさらに分画・精製して得られる一部分などであってもよい。そのような分画・精製して得られる一部分としては、例えば、水や親水性有機溶媒(メタノールやエタノールなど)又はこれらの混合溶媒などの一般的な抽出溶媒で抽出される一部分などを使用することができ、例えば、90容量%エタノール抽出法、80容量%エタノール抽出法、70容量%エタノール抽出法、50容量%エタノール抽出法、30容量%エタノール抽出法などにより抽出して得られる一部分などを使用することができる。しかし簡便には、ダイズタンパク質をサーモリシンで分解して得られる多種多様なペプチドを実質的に全て含んだ状態でそのまま用いる。ダイズタンパク質のサーモリシン分解物の育毛効果(活性)は、例えば、後述の実施例等に記載の方法に従って確認することができる。 The soybean protein degradation product by thermolysin used in the present invention may contain substantially all of a wide variety of peptides obtained by the degradation reaction of soybean protein by thermolysin, or such a wide variety of peptides. The peptide may be a portion obtained by further fractionation and purification by a known method using the presence or absence of the hair-growth effect of the present invention as an index. As a part obtained by such fractionation / purification, for example, a part extracted with water or a hydrophilic organic solvent (such as methanol or ethanol) or a general extraction solvent such as a mixed solvent thereof is used. For example, a portion obtained by extraction by 90 volume% ethanol extraction method, 80 volume% ethanol extraction method, 70 volume% ethanol extraction method, 50 volume% ethanol extraction method, 30 volume% ethanol extraction method, etc. Can be used. However, for convenience, the soy protein is used as it is in a state of containing substantially all of a wide variety of peptides obtained by decomposing the protein with thermolysin. The hair-growth effect (activity) of the thermolysin decomposition product of soybean protein can be confirmed, for example, according to the method described in Examples and the like described later.
本発明に使用するダイズタンパク質のサーモリシン分解物の平均分子量は、好ましくは300〜10000である。該平均分子量は、細胞への浸透性を高めてより高い効果を得る、という観点から、より好ましくは400〜5000であり、さらに好ましくは500〜3500であり、さらにより好ましくは550〜3200である。分解物の平均分子量は、当業者に公知の任意の方法により測定することができ、例えば、後述の実施例に記載のようにしてゲル浸透クロマトグラフィー(GPC)法により容易に測定することができる。
本願育毛剤中におけるダイズタンパク質のサーモリシン分解物の含有量は、例えば、0.0001〜99重量%、より好ましくは0.001〜80重量%、さらに好ましくは0.01〜50重量%、特に好ましくは0.1〜30重量%である。
The average molecular weight of the thermolysin degradation product of soybean protein used in the present invention is preferably 300 to 10,000. The average molecular weight is more preferably 400 to 5000, further preferably 500 to 3500, and still more preferably 550 to 3200, from the viewpoint of increasing the permeability to cells and obtaining a higher effect. . The average molecular weight of the degradation product can be measured by any method known to those skilled in the art, and for example, it can be easily measured by gel permeation chromatography (GPC) as described in the Examples below. .
The content of the thermolysin degradation product of soybean protein in the present hair restorer is, for example, 0.0001 to 99% by weight, more preferably 0.001 to 80% by weight, still more preferably 0.01 to 50% by weight, particularly preferably. Is 0.1 to 30% by weight.
本発明の育毛剤の適用量は特に制限されず、状態に応じて適宜調整される。しかし、通常は、グリチルリチン酸類の投与量が、1〜2000μg/cm2/日となるような量、好ましくは当該投与量が10〜1000μg/cm2/日となるような量、さらに好ましくは当該投与量が50〜500μg/cm2/日となるような量であり、かつその中に含まれるダイズタンパク質のサーモリシン分解物の投与量が、0.001〜1000μg/cm2/日となるような量、好ましくは当該投与量が0.01〜500μg/cm2/日となるような量、さらに好ましくは当該投与量が0.1〜300μg/cm2/日となるような量とするのがよい。 The application amount of the hair restorer of the present invention is not particularly limited, and is appropriately adjusted according to the state. Normally, however, the dosage of glycyrrhizin acids, amounts such that 1~2000μg / cm 2 / day, preferably in an amount amount the administered such that 10~1000μg / cm 2 / day, more preferably the an amount such that the dosage is 50-500 / cm 2 / day, and such dosage thermolysin hydrolyzate of soy protein contained therein, the 0.001~1000μg / cm 2 / day The amount is preferably such that the dosage is 0.01 to 500 μg / cm 2 / day, more preferably the dosage is 0.1 to 300 μg / cm 2 / day. Good.
後述の実施例に示すように、グリチルリチン酸類とダイズタンパク質のサーモリシン分解物の併用によって、グリチルリチン酸類の育毛効果が顕著に増強されることが確認されている。 As shown in Examples described later, it has been confirmed that the hair-growth effect of glycyrrhizic acids is remarkably enhanced by the combined use of glycyrrhizic acids and a thermolysin degradation product of soybean protein.
本明細書において用語「育毛」とは、発毛や養毛、脱毛予防などのあらゆる概念を含む広義の意であり、例えば、毛包内で毛の新たな発生を促す、既に毛包内で発生した毛を健全に発育させる等、毛の発育・成長を促すように有利にはたらく全ての作用を包含する。なお、ここで毛とは、ヒトを含む動物における身体に生える任意の毛を意味し、例えば、毛髪、頭髪、眉毛、睫毛、口髭、顎鬚、胸毛、背部毛などのあらゆる体毛を意味する。 In this specification, the term “hair growth” is a broad meaning including all concepts such as hair growth, hair restoration, and hair loss prevention. For example, in hair follicles, which promotes new generation of hair. It includes all actions that advantageously work to promote the growth and growth of hair, such as healthy growth of generated hair. Here, the hair means any hair that grows on the body of animals including humans, for example, all body hair such as hair, head hair, eyebrows, eyelashes, mustache, beard, chest hair, and back hair.
育毛効果(又は育毛活性)を有することの確認は、自体公知の方法、例えば、生体(例えば、ヒト頭皮やマウス背毛部など)に被験物を適用(例えば、塗布又は噴霧等)して、毛の発生量や発生速度の増加等を観察する方法、毛乳頭細胞や毛包上皮細胞(毛母細胞や外毛根鞘細胞を含む)などに被験物を作用させて、その細胞数の増加等を観察する方法等により行うことができる。或いは後述の実施例に記載のようにして、毛包器官培養系(例えば、ラットの髭器官培養毛)に被験物を作用させて、その培養毛の伸長度を観察することによっても可能である。 Confirmation of having a hair-growth effect (or hair-growth activity) is a method known per se, for example, applying a test substance to a living body (for example, human scalp or mouse back hair) (for example, application or spraying), A method for observing an increase in the amount and rate of hair generation, an increase in the number of cells by causing the test substance to act on hair papilla cells and hair follicle epithelial cells (including hair matrix cells and outer root sheath cells), etc. It can be performed by a method of observing. Alternatively, as described in the Examples below, it is also possible to cause the test substance to act on a hair follicle organ culture system (for example, rat's heel organ culture hair) and observe the elongation of the culture hair. .
本発明の育毛剤は、有効成分としてグリチルリチン酸類とダイズタンパク質のサーモリシン分解物のみを含むものであってもよいが、必要に応じてさらなる種々の他の有効成分を含んでいてもよい。このような他の有効成分としては、例えば、細胞賦活剤、血行促進剤、抗男性ホルモン剤、皮脂分泌抑制剤、免疫抑制剤、抗ヒスタミン剤、殺菌消毒剤、局所刺激剤、角質軟化剤、消炎剤、抗アポトーシス剤等が挙げられるが、これらに限定されない。具体的には、例えば、パントテン酸およびその誘導体、プラセンタエキス、感光素、ニンジンエキス、ビオチン、モノニトログアヤコール、塩化カルプロニウムまたはその水和物、ビタミンEおよびその誘導体、センブリエキス、トウガラシチンキ、セファランチン、ニコチン酸およびその誘導体、エストラジオール、エチニルエストラジオール、ランジック酸、ミノキシジルおよびその類縁体や誘導体、5α還元酵素阻害剤、12-テトラデカノイルフォルボル-13-アセテート(12-Tetradecanoylphorbol-13-acetate)、オウセイ、カギカズラ、オオアザミ、ヘンナといった生薬、安息香酸エストラジオール、ジフェンヒドラミン、レゾルシン、ヒノキチオール、l-メントール、トウガラシチンキ、サリチル酸、カシュウ成分、チクセツニンジン成分、パンテノール、二硫化セレン、塩酸ピリドキシン、オクトピロックス、ジンクピリチオン、イオウ、ピロクトンオラミン、グリチルレチン酸ステアリル、アラントイン、ジアルキルモノアミン誘導体、センブリ抽出液、シソエキス、ブクリョウエキス、硝酸ミコナゾール、安息香酸、サリチル酸ナトリウム、フィトステロール、ワイン酵母エキス、タカナール、エチニルエストラジオール、イソプロピルメチルフェノール、セファランチンビオチン、D-パントテニルアルコール、ジアルキルモノ誘導体、ヒウキオコシエキス、ボタンエキス、シナノエキス、エピネエキス、ソフォラ抽出物、クララエキス、クジンエキス、ショウキョウエキス、6-ベンジルアミノプリン、ペンタデカン酸グリセリド、t-フラバノン、クアチャララーテエキス、アマチャ抽出物、アデノシン、フコイダン、パントテニルエチルエーテル等から選択される、1種または2種以上を組合せて用いることができる。 The hair restorer of the present invention may contain only glycyrrhizic acids and a thermolysin degradation product of soybean protein as active ingredients, but may contain various other active ingredients as necessary. Examples of such other active ingredients include cell activators, blood circulation promoters, anti-androgen hormone agents, sebum secretion inhibitors, immunosuppressants, antihistamines, bactericidal antiseptics, local stimulants, keratin softeners, anti-inflammatory agents. , Anti-apoptotic agents and the like, but are not limited thereto. Specifically, for example, pantothenic acid and derivatives thereof, placenta extract, photosensitizer, carrot extract, biotin, mononitroguaiacol, carpronium chloride or hydrate thereof, vitamin E and derivatives thereof, assembly extract, red pepper tincture, cephalanthin, Nicotinic acid and its derivatives, estradiol, ethinylestradiol, landic acid, minoxidil and its analogs and derivatives, 5α reductase inhibitor, 12-tetradecanoylphorbol-13-acetate (12-Tetradecanoylphorbol-13-acetate), goose Herbal medicines such as katsura, milk thistle, henna, estradiol benzoate, diphenhydramine, resorcin, hinokitiol, l-menthol, red pepper tincture, salicylic acid, ginger component, prickly carrot component, pante , Selenium disulfide, pyridoxine hydrochloride, octopirox, zinc pyrithione, sulfur, piroctone olamine, stearyl glycyrrhetinate, allantoin, dialkyl monoamine derivatives, assembly extract, perilla extract, buccal extract, miconazole nitrate, benzoic acid, sodium salicylate , Phytosterols, wine yeast extract, takanal, ethinylestradiol, isopropylmethylphenol, cephalanthin biotin, D-pantothenyl alcohol, dialkyl monoderivatives, marsh extract, button extract, shinano extract, epine extract, sophora extract, clara extract, kudin extract , Ginger extract, 6-benzylaminopurine, pentadecanoic acid glyceride, t-flavanone, quachalate extract, amacha One or a combination of two or more selected from extracts, adenosine, fucoidan, pantothenyl ethyl ether and the like can be used.
また上述のような他の有効成分の含有量は、所望される効果や適用される被験体の年齢、性別、状態などの種々の要因により適宜変動され得るが、例えば、育毛剤の全体重量に対して0.001〜50重量%、好ましくは0.001〜10重量%、より好ましくは0.001〜5重量%などである。しかし、これらに限定されない。 Further, the content of other active ingredients as described above can be appropriately varied depending on various effects such as desired effects and age, sex, and condition of the subject to be applied. On the other hand, it is 0.001 to 50% by weight, preferably 0.001 to 10% by weight, more preferably 0.001 to 5% by weight. However, it is not limited to these.
本発明の育毛剤は、発明の効果や製剤的安定性、生体への安全性などを損なわない限りにおいて、上記成分の他に用途あるいは剤形などに応じて、医薬品、医薬部外品、化粧品、食品などに通常使用され得る任意の成分を適宜配合しても良い。配合できる成分としては、特に制限されないが、例えば、担体、基剤、添加剤などが挙げられる。具体的には、例えば、糖類(例えば、マンニトール、乳糖、デキストラン等)、セルロース類(例えば、ヒドロキシプロピルセルロース、メチルセルロース、結晶性セルロース等)、水難溶性ガム類(例えば、アラビアガム、トラガントガム等)、架橋ビニル重合体、脂質類、水、油脂類、鉱物油類、ロウ類、脂肪酸類、シリコーン油類、ステロール類、エステル類、金属石鹸類、アルコール、界面活性剤、可溶化成分、乳化剤、油分、安定化剤、増粘剤、防腐剤、結合剤、滑沢剤、分散剤、pH調整剤、保湿剤、紫外線吸収剤、キレート剤、経皮吸収促進剤、抗酸化剤、崩壊剤、可塑剤、緩衝剤、ビタミン類、アミノ酸類、着色剤、香料等がから選択される1種または2種以上を組合せて用いることができる。さらに本発明の育毛剤は、リポソームのような公知のDDS担体とともに用いることも好ましい。 The hair restorer of the present invention is a pharmaceutical, quasi-drug, cosmetic, depending on the use or dosage form in addition to the above components, as long as the effects of the invention, formulation stability, safety to the living body, etc. are not impaired. Any component that can be generally used in foods may be appropriately blended. Although it does not restrict | limit especially as a component which can be mix | blended, For example, a support | carrier, a base, an additive etc. are mentioned. Specifically, for example, saccharides (e.g., mannitol, lactose, dextran, etc.), celluloses (e.g., hydroxypropylcellulose, methylcellulose, crystalline cellulose, etc.), poorly water-soluble gums (e.g., gum arabic, gum tragacanth, etc.), Cross-linked vinyl polymers, lipids, water, fats and oils, mineral oils, waxes, fatty acids, silicone oils, sterols, esters, metal soaps, alcohol, surfactants, solubilizing components, emulsifiers, oil content , Stabilizers, thickeners, preservatives, binders, lubricants, dispersants, pH adjusters, moisturizers, UV absorbers, chelating agents, transdermal absorption promoters, antioxidants, disintegrants, plastics One or two or more selected from agents, buffers, vitamins, amino acids, colorants, fragrances and the like can be used. Furthermore, the hair restorer of the present invention is also preferably used with a known DDS carrier such as a liposome.
界面活性剤としては、医薬品、医薬部外品または化粧品分野において外用剤の成分として用いられるものであれば特に限定されず、アニオン系、カチオン系、両性及び非イオン系等の種類の別を問わず、任意の界面活性剤を用いることができる。アニオン界面活性剤としては、セッケン用素地、ラウリン酸ナトリウム、パルミチン酸ナトリウム、ヤシ油脂脂肪酸カリウムなどの脂肪酸セッケン、アルキルエーテルカルボン酸塩、脂肪酸アミドエーテルカルボン酸塩、アシル乳酸塩、N−アシルサルコシン塩、N−アシルグルタミン酸塩、N−アシルアラニン塩、N−アシルメチルアラニン塩、N−アシルメチルタウリン塩、N−アシル−ω−アミノ酸塩、アルカンスルホン酸塩、α−オレフィンスルホン酸塩、α―スルホ脂肪酸メチルエステル塩、アルキルスルホコハク酸塩、アシルイセチオン酸塩、アルキルグリシジルエーテルスルホン酸塩、モノラウロイルモノエタノールアミドポリオキシエチレンスルホコハク酸ナトリウム、ラウリルポリプロピレングリコールスルホコハク酸ナトリウム、ジ−2−エチルヘキシルスルホコハク酸ナトリウム、POEスルホコハク酸ラウリル二ナトリウム、アルキルスルホ酢酸塩、アルキルベンゼンスルホン酸塩、アルキルナフタレンスルホン酸塩、N−アシルメチルタウリン塩、ホルマリン縮合系スルホン酸塩、アルキル硫酸エステル塩、アルキルエーテル硫酸エステル塩、アルキルアリールエーテル硫酸塩、脂肪酸アルカノールアミド硫酸エステル塩、モノアシルグリセリン硫酸エステル塩、モノアルキルリン酸エステル塩、ポリオキシエチレンアルキルエーテルリン酸塩、アルキルアリールエーテルリン酸塩、脂肪酸アミドエーテルリン酸塩等が挙げられる。特に好ましくは、N−アシルグルタミン酸塩、N−アシルアラニン塩、N−アシルメチルアラニン塩、α−オレフィンスルホン酸塩、アルキル硫酸エステル塩、アルキルエーテル硫酸エステル塩、ポリオキシエチレンアルキルエーテルリン酸塩が挙げられる。 The surfactant is not particularly limited as long as it is used as a component of an external preparation in the pharmaceutical, quasi-drug or cosmetic field, and may be any kind of anionic, cationic, amphoteric and nonionic. Any surfactant can be used. Anionic surfactants include soap bases, fatty acid soaps such as sodium laurate, sodium palmitate, coconut oil fatty acid potassium, alkyl ether carboxylates, fatty acid amide ether carboxylates, acyl lactates, N-acyl sarcosine salts N-acyl glutamate, N-acyl alanine salt, N-acyl methyl alanine salt, N-acyl methyl taurine salt, N-acyl-ω-amino acid salt, alkane sulfonate, α-olefin sulfonate, α- Sulfo fatty acid methyl ester salt, alkyl sulfosuccinate, acyl isethionate, alkyl glycidyl ether sulfonate, monolauroyl monoethanolamide sodium polyoxyethylene sulfosuccinate, sodium lauryl polypropylene glycol sulfosuccinate , Sodium di-2-ethylhexyl sulfosuccinate, disodium lauryl POE sulfosuccinate, alkyl sulfoacetate, alkyl benzene sulfonate, alkyl naphthalene sulfonate, N-acylmethyl taurate, formalin condensation sulfonate, alkyl sulfate Ester salt, alkyl ether sulfate, alkyl aryl ether sulfate, fatty acid alkanolamide sulfate, monoacylglycerol sulfate, monoalkyl phosphate, polyoxyethylene alkyl ether phosphate, alkyl aryl ether phosphate Examples thereof include salts and fatty acid amide ether phosphates. Particularly preferably, N-acyl glutamate, N-acyl alanine, N-acyl methyl alanine, α-olefin sulfonate, alkyl sulfate, alkyl ether sulfate, polyoxyethylene alkyl ether phosphate are used. Can be mentioned.
また、カチオン界面活性剤としては、アルキルアミン塩、脂肪酸アミドアミン塩、エステル含有3級アミン、アーコベル型3級アミン、アルキル4級アンモニウム塩等のアミン塩、モノアルキル型4級アンニモニウム塩、ジアルキル型4級アンモニウム塩、トリアルキル型4級アンモニウム塩、ベンザルコニウム型4級アンニモニウム塩、モノアルキルエーテル型4級アンモニウム塩等のアルキル4級アンモニウム塩、アルキルピリジニウム塩、アルキルイソキノリウム塩、塩化ベンゼトニウム等の環式4級アンニモニウム塩が挙げられる。特に好ましくは、モノアルキル型4級アンモニウム塩、ジアルキル型4級アンニモニウム塩、ベンザルコニウム型4級アンニモニウム塩が挙げられる。 Examples of cationic surfactants include alkylamine salts, fatty acid amide amine salts, amine salts such as ester-containing tertiary amines, archebel type tertiary amines, alkyl quaternary ammonium salts, monoalkyl type quaternary annimmonium salts, and dialkyl types. Quaternary ammonium salts, trialkyl type quaternary ammonium salts, benzalkonium type quaternary annimonium salts, alkyl quaternary ammonium salts such as monoalkyl ether type quaternary ammonium salts, alkyl pyridinium salts, alkyl isoquinolium salts, chloride And cyclic quaternary annimonium salts such as benzethonium. Particularly preferred are monoalkyl type quaternary ammonium salts, dialkyl type quaternary annimmonium salts, and benzalkonium type quaternary annimonium salts.
両性界面活性剤としては、アミノ酢酸ベタイン型両性界面活性剤、スルホベタイン型両性界面活性剤等のベタイン型両性界面活性剤、グリシン型両性界面活性剤、アミノプロピオン酸型両性界面活性剤等のアミノ酸型界面活性剤が挙げられる。特に好ましくは、アミノ酢酸ベタイン型両性界面活性剤、グリシン型両性界面活性剤が挙げられる。 As the amphoteric surfactant, amino acid such as aminoacetic acid betaine type amphoteric surfactant, betaine type amphoteric surfactant such as sulfobetaine type amphoteric surfactant, glycine type amphoteric surfactant, aminopropionic acid type amphoteric surfactant, etc. Type surfactants. Particularly preferred are aminoacetic acid betaine-type amphoteric surfactants and glycine-type amphoteric surfactants.
非イオン界面活性剤としては、例えばモノステアリン酸プロピレングリコールなどのプロピレングリコールモノ脂肪酸エステル、エチレングリコールモノ脂肪酸エステル、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、モノステアリン酸グリセリン、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、メチルグルコシド脂肪酸エステル、アルキルポリグルコシドなどの多価アルコールの脂肪酸エステル、多価アルコールのアルキルエーテル、POEアルキルエーテル、POEアルキルフェニルエーテル、POEフィトステロール、POEコレスタノール、POEポリオキシプロピレンアルキルエーテルなどのPOEエーテル、POEモノ脂肪酸エステル、POEグリコールジ脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、POEソルビタン脂肪酸エステル、POEソルビトール脂肪酸エステル、POEメチルグルコシド脂肪酸エステル、POEヒマシ油、POE硬化ヒマシ油、POE動植物油、POEアルキルエーテル脂肪酸エステル、POEポリオキシプロピレングリコールなどのエーテルエステル、ヤシ油脂肪酸ジエタノールアミドなどが挙げられる。特に好ましくは、モノステアリン酸グリセリン、ポリグリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、POEアルキルエーテル、POEアルキルフェニルエーテル、POEポリオキシプロピレンアルキルエーテル、POEソルビタン脂肪酸エステル、POEソルビトール脂肪酸エステル、POE硬化ヒマシ油、ヤシ油脂肪酸ジエタノールアミドが挙げられる。 Nonionic surfactants include, for example, propylene glycol monofatty acid esters such as propylene glycol monostearate, ethylene glycol monofatty acid ester, mono cottonseed oil fatty acid glycerin, monoerucic acid glycerin, sesquioleate glycerin, monostearate glycerin, polyglycerin fatty acid Esters, sorbitan fatty acid esters, sucrose fatty acid esters, methyl glucoside fatty acid esters, fatty acid esters of polyhydric alcohols such as alkyl polyglucosides, polyhydric alcohol alkyl ethers, POE alkyl ethers, POE alkyl phenyl ethers, POE phytosterols, POE cholestanols , POE ether such as POE polyoxypropylene alkyl ether, POE mono-fatty acid ester, POE group Cold di fatty acid ester, polyoxyethylene glycerin fatty acid ester, POE sorbitan fatty acid ester, POE sorbitol fatty acid ester, POE methyl glucoside fatty acid ester, POE castor oil, POE hydrogenated castor oil, POE animal and vegetable oil, POE alkyl ether fatty acid ester, POE polyoxypropylene Examples include ether esters such as glycol, and palm oil fatty acid diethanolamide. Particularly preferably, glyceryl monostearate, polyglycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, POE alkyl ether, POE alkylphenyl ether, POE polyoxypropylene alkyl ether, POE sorbitan fatty acid ester, POE sorbitol fatty acid ester, POE Examples include hydrogenated castor oil and coconut oil fatty acid diethanolamide.
他の界面活性剤としては、POEアルキルアミン、POE脂肪酸アミド、アルキルジエタノールアミド、アルキルアミンオキシド、POEアルキルメルカプタン、高分子界面活性剤、フッ素系界面活性剤、シリコーン系界面活性剤、ポリペプチド誘導体、天然界面活性剤等が挙げられる。 Other surfactants include POE alkylamines, POE fatty acid amides, alkyldiethanolamides, alkylamine oxides, POE alkyl mercaptans, polymer surfactants, fluorosurfactants, silicone surfactants, polypeptide derivatives, And natural surfactants.
前記界面活性剤の塩としては、アンモニウム塩、アルカリ金属(ナトリウム、カリウム等)、アルカリ土類金属(カルシウム、マグネシウム等)、亜鉛、アルミニウム等の金属類が例示できる。 Examples of the salt of the surfactant include ammonium salts, alkali metals (such as sodium and potassium), alkaline earth metals (such as calcium and magnesium), zinc, and aluminum.
本発明の育毛剤は、当該分野で公知の任意の方法を利用して、ダイズタンパク質のサーモリシン分解物を配合し、さらに必要に応じて上述のような他の有効成分や担体、基剤、添加剤等を配合することにより、常法で製造することができる。 The hair restorer of the present invention is blended with a thermolysin degradation product of soybean protein using any method known in the art, and further, if necessary, other active ingredients, carriers, bases, additions as described above It can be manufactured by a conventional method by blending an agent and the like.
本発明の育毛剤は、医薬品、医薬部外品、食品、化粧品などとして幅広く利用可能な任意の製剤であり得るが、好ましくは、医薬品、医薬部外品、または化粧品として利用可能な製剤である。 The hair-restoring agent of the present invention can be any preparation that can be widely used as a pharmaceutical, quasi-drug, food, cosmetic, etc., but is preferably a preparation that can be used as a pharmaceutical, quasi-drug, or cosmetic. .
本発明の育毛剤の剤形は特に制限されず、例えば、本発明の育毛剤は、内服剤、外用剤、注射用剤など、任意の剤形をとることができるが、外用剤が好ましい。 The dosage form of the hair restorer of the present invention is not particularly limited. For example, the hair restorer of the present invention can take any dosage form such as an internal preparation, an external preparation, and an injection, but an external preparation is preferred.
外用剤としては、医薬品、医薬部外品、化粧品などで一般的な任意の形態をとり得、例えば、液状、乳液状、クリーム状、ローション状、ペースト状、ムース状、ジェル状、シート状(基材担持)、エアゾール状、スプレー状、オイル状、パック状、ゲル状、軟膏状などの形態であり得るが、これらに限定されない。 As an external preparation, it can take any general form for pharmaceuticals, quasi drugs, cosmetics, etc., for example, liquid, emulsion, cream, lotion, paste, mousse, gel, sheet ( Substrate), aerosol, spray, oil, pack, gel, ointment and the like, but is not limited thereto.
本発明の育毛剤を含有する製剤としては、例えば医薬品、医薬部外品、化粧品、食品などとして利用可能な製剤を含み、特に具体的には、例えば育毛用製品、養毛用製品、頭髪用化粧品(例えば、シャンプー、ヘアコンディショナー、頭皮用ローション、頭皮用クリーム、ヘアトニック)、スキンケア用化粧品(例えば、化粧水、ローション、クリーム、顔用クリーム、顔用ローション、乳液、パック、液体洗顔料、石鹸)、ボディケア化粧品(例えば、全身クリーム、全身ローション、石鹸、液体洗浄料、入浴剤)、紫外線防御化粧料(例えば、日焼け止めクリーム、日焼け止めローション、サンタンクリーム、サンタンローション)、メーキャップ化粧品(例えば、アイライナー、アイブロー)があり、好ましくはシャンプー、ヘアコンディショナー、頭皮用ローション、頭皮用クリーム、ヘアトニック、全身クリーム、全身ローション、顔用クリーム、顔用ローション、アイライナー、アイブローであり得るが、これらに限定されない。 Examples of the preparation containing the hair restorer of the present invention include preparations that can be used as, for example, pharmaceuticals, quasi drugs, cosmetics, foods, and the like. Cosmetics (eg shampoo, hair conditioner, scalp lotion, scalp cream, hair tonic), skin care cosmetics (eg lotion, lotion, cream, facial cream, facial lotion, milky lotion, pack, liquid facial cleanser, Soap), body care cosmetics (eg whole body cream, whole body lotion, soap, liquid cleaning agent, bath preparation), UV protection cosmetics (eg sunscreen cream, sunscreen lotion, suntan cream, suntan lotion), makeup cosmetics ( For example, eyeliner, eyebrow), preferably shampoo, haircon Ishona, scalp lotions, scalp creams, hair tonic, whole body cream, whole body lotions, face creams, face lotions, eye liner, but may be an eyebrow, but are not limited to these.
また、上述の製剤中のグリチルリチン酸類の含有量は、所望される効果や利用される製剤などの種々の要因により適宜変動され得るが、例えば、製剤全体重量に対して0.01〜99重量%、好ましくは0.05〜50重量%などである。しかし、これらに限定されない。 Further, the content of glycyrrhizic acids in the above-mentioned preparation can be appropriately varied depending on various factors such as desired effects and the preparation to be used, but for example, 0.01 to 99% by weight with respect to the total weight of the preparation Preferably, it is 0.05 to 50% by weight. However, it is not limited to these.
また、上述の製剤中のダイズタンパク質のサーモリシン分解物の含有量は、所望される効果や利用される製剤などの種々の要因により適宜変動され得るが、例えば、製剤全体重量に対して0.0001〜99重量%、好ましくは0.001〜80重量%、より好ましくは0.01〜50重量%などである。しかし、これらに限定されない。 Moreover, the content of the thermolysin degradation product of soybean protein in the above-mentioned preparation can be appropriately varied depending on various factors such as a desired effect and a preparation to be used. -99 wt%, preferably 0.001-80 wt%, more preferably 0.01-50 wt%. However, it is not limited to these.
本発明の育毛剤及び育毛剤を含有する製剤は常法に従って用いられる。例えば、外用剤の場合には、育毛効果の望まれる箇所(例えば、頭髪、眉毛、睫毛、口髭、顎鬚、胸毛、背部毛、腋毛、陰毛、手及び腕の毛、すね毛等、体に生える任意の毛)の部分の皮膚に、直接塗布又は噴霧等をすることによって適用することができる。また本発明の育毛剤は、その形態や所望される効果の程度等に応じて、1日あたり1回から複数回(例えば、2回、3回など)に分けて投与することができる。 The hair restorer of the present invention and the preparation containing the hair restorer are used in accordance with conventional methods. For example, in the case of an external preparation, it is applied to the body where the hair-growth effect is desired (for example, head hair, eyebrows, eyelashes, mustache, beard, chest hair, back hair, eyelashes, pubic hair, hand and arm hair, shank hair, etc. It can be applied by direct application or spraying on the skin of any hair). In addition, the hair restorer of the present invention can be administered in one to several times (for example, twice, three times, etc.) per day depending on the form and the degree of desired effect.
以下に、実施例に基づいて本発明を詳細に説明するが、本発明はこれらの実施例によって限定されるものではない。 EXAMPLES The present invention will be described in detail below based on examples, but the present invention is not limited to these examples.
調製例1:ダイズタンパク質のサーモリシン分解物の調製
粉末状分離ダイズタンパク質(製品名「PR-800」、不二製油株式会社製)50gを2Lの蒸留水に分散し、0.1N NaOHでpH8.0に調整した。500mgのサーモリシン(EC3.4.24.27、Bacillus thermoproteolyticus由来、製品名「サモアーゼPC10F」、大和化成株式会社製、100 units/mg)を添加して、60℃で15時間での分解を行なった。反応後、100℃で10分間煮沸してサーモリシンを失活させた。放冷後、25gのろ過助剤(ラジオライト500、昭和化学工業株式会社)を添加し、撹拌した後、ろ過を行なった。得られたろ液を500mlまで減圧濃縮し、その後凍結乾燥をして、最終的に約26gのダイズタンパク質のサーモリシン分解物を得た。
Preparation Example 1: Preparation of Thermolysin Degradation Product of Soy Protein 50 g of powdered soy protein (product name “PR-800”, manufactured by Fuji Oil Co., Ltd.) was dispersed in 2 L of distilled water, and pH 8.0 with 0.1 N NaOH. Adjusted. 500 mg of thermolysin (EC3.4.24.27, derived from Bacillus thermoproteolyticus, product name “Samorose PC10F”, manufactured by Daiwa Kasei Co., Ltd., 100 units / mg) was added, and degradation was performed at 60 ° C. for 15 hours. After the reaction, the thermolysin was inactivated by boiling at 100 ° C. for 10 minutes. After allowing to cool, 25 g of filter aid (Radiolite 500, Showa Chemical Industry Co., Ltd.) was added and stirred, followed by filtration. The obtained filtrate was concentrated under reduced pressure to 500 ml, and then freeze-dried to finally obtain about 26 g of a thermolysin degradation product of soybean protein.
このようにして得られた分解物の平均分子量をGPC法により測定した。ダイズタンパク質サーモリシン分解物を25mM Tris-HCl緩衝液(150mM NaCl含有、pH7.5)に溶解し、1mg/mLの被験溶液を調製した。HPLCカラム Superdex peptide HR(10mm I.D.×30cm,Amersham Biosciences社製)を同じ緩衝液で平衡化し、このカラムに被験溶液を100μL注入した。カラムの流速は0.5mL/分、カラム温度は室温、ペプチドの検出は214nmで行なった。
分子量既知のペプチド標品として、Cytochrome C(シグマ社製、分子量12327)、Aprotinin(シグマ社製、分子量6518)、Hexaglycine(シグマ社製、分子量360)、Triglycine(シグマ社製、分子量189)、及びGlycine(シグマ社製、分子量75)を用いた。溶出時間から分子量分布及びピーク平均分子量を推定した。
その結果、コラプラスNのピーク平均分子量は711、分子量分布は100〜30000であることが推定された。
ここで、「ピーク平均分子量」とは、クロマトグラフのピークトップ(最も強い強度のピーク)の溶出時間に対応する分子量を意味する。
The average molecular weight of the decomposition product thus obtained was measured by the GPC method. A soybean protein thermolysin degradation product was dissolved in 25 mM Tris-HCl buffer (containing 150 mM NaCl, pH 7.5) to prepare a 1 mg / mL test solution. HPLC column Superdex peptide HR (10 mm ID × 30 cm, manufactured by Amersham Biosciences) was equilibrated with the same buffer, and 100 μL of the test solution was injected into this column. The flow rate of the column was 0.5 mL / min, the column temperature was room temperature, and the peptide was detected at 214 nm.
As peptide preparations with known molecular weights, Cytochrome C (Sigma, molecular weight 12327), Aprotinin (Sigma, molecular weight 6518), Hexaglycine (Sigma, molecular weight 360), Triglycine (Sigma, molecular weight 189), and Glycine (manufactured by Sigma, molecular weight 75) was used. Molecular weight distribution and peak average molecular weight were estimated from the elution time.
As a result, it was estimated that the peak average molecular weight of Collaplus N was 711 and the molecular weight distribution was 100-30000.
Here, “peak average molecular weight” means the molecular weight corresponding to the elution time of the peak top (the strongest peak) of the chromatograph.
調製例2:ダイズタンパク質のサーモリシン分解物(エタノール抽出物)の調製
粉末状分離ダイズタンパク質(製品名「PR-800」、不二製油株式会社製)50gを2Lの蒸留水に分散し、0.1N NaOHでpH8.0に調整した。500mgのサーモリシン(EC3.4.24.27、Bacillus thermoproteolyticus由来、製品名「サモアーゼPC10F」、大和化成株式会社製、100 units/mg)を添加して、60℃で15時間での分解を行なった。反応後、100℃で10分間煮沸してサーモリシンを失活させた。放冷後、8.0Lのエタノールを添加し混合した(エタノールの終濃度:80%)。25gのろ過助剤(ラジオライト500、昭和化学工業株式会社)を添加し、撹拌した後、ろ過を行なった。得られたろ液を500mLまで減圧濃縮し、その後凍結乾燥をして、最終的に約20.2gのダイズタンパク質のサーモリシン分解物(エタノール抽出物)を得た。
Preparation Example 2: Preparation of Thermolysin Degradation Product (Ethanol Extract) of Soy Protein 50 g of powdered soy protein (product name “PR-800”, manufactured by Fuji Oil Co., Ltd.) was dispersed in 2 L of distilled water and 0.1 N The pH was adjusted to 8.0 with NaOH. 500 mg of thermolysin (EC3.4.24.27, derived from Bacillus thermoproteolyticus, product name “Samorose PC10F”, manufactured by Daiwa Kasei Co., Ltd., 100 units / mg) was added, and degradation was performed at 60 ° C. for 15 hours. After the reaction, the thermolysin was inactivated by boiling at 100 ° C. for 10 minutes. After allowing to cool, 8.0 L of ethanol was added and mixed (final concentration of ethanol: 80%). 25 g of filter aid (Radiolite 500, Showa Chemical Industry Co., Ltd.) was added and stirred, followed by filtration. The obtained filtrate was concentrated under reduced pressure to 500 mL and then freeze-dried to finally obtain about 20.2 g of a soybean protein thermolysin degradation product (ethanol extract).
実施例1:ラット髭器官培養毛の伸長促進試験
本発明のサーモリシン分解物の育毛効果を、毛包の器官培養系としてラットの髭器官培養毛を用いて確認した。
Wistar系新生ラットの髭毛包器官を外科的に摘出した。ステンレスグリッドを入れた器官培養シャーレ(Falcon 3037)に表1に記載の濃度に調整した各被験薬を含有する培地(RPMI 1640)(0.4 mL)を添加し、その上に摘出した髭毛包器官を10器官ずつ並べた。無菌条件下、5%CO2、90%O2の気相下にて、31℃で培養した。5日後、毛幹の長さを測定し、試験開始前の測定値との差から、毛幹の伸長量を計算した。対照群として、被験薬を含有しない培地を用いて同様に実験した。結果を表1及び図1に示す。なお、図1において、Controlは対照、Glytylはグリチルリチン酸ジカリウムを意味する。
Example 1 Test for Promoting Growth of Rat Vaginal Organ Culture Hair The hair growth effect of the thermolysin degradation product of the present invention was confirmed using rat vaginal organ culture hair as a hair follicle organ culture system.
The ciliary organs of Wistar newborn rats were surgically removed. A medium (RPMI 1640) (0.4 mL) containing each test drug adjusted to the concentration shown in Table 1 was added to an organ culture petri dish (Falcon 3037) containing a stainless steel grid, and the eyelashes excised thereon Ten wrapping organs were arranged. The cells were cultured at 31 ° C. under aseptic conditions in a gas phase of 5% CO 2 and 90% O 2 . After 5 days, the length of the hair shaft was measured, and the elongation amount of the hair shaft was calculated from the difference from the measured value before the start of the test. As a control group, the same experiment was performed using a medium containing no test drug. The results are shown in Table 1 and FIG. In FIG. 1, Control means control, and Glytyl means dipotassium glycyrrhizinate.
表1及び図1に示される通り、本発明のサーモリシン分解物は、器官培養系においてグリチルリチン酸類の成長期毛の伸長促進効果を顕著に増強することが認められた。この結果は、本発明の育毛剤が、生体においても同様に顕著に高い育毛効果を奏し得ることを示すものである。 As shown in Table 1 and FIG. 1, it was confirmed that the thermolysin degradation product of the present invention remarkably enhances the growth promoting effect of glycyrrhizic acids on the growing hair in the organ culture system. This result shows that the hair-restoring agent of the present invention can exhibit a significantly high hair-restoring effect in the living body as well.
以下に製剤実施例を挙げるが、本発明はこれらの実施例に限られるものではない。
製剤実施例1(外用育毛剤)
下記の各成分を秤量し、精製水にて100mLに調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1500) 1.0 g
レゾルシン 1.0 g
パントテニルエチルエーテル 0.1 g
プロピレングリコール 10.0 g
95%エタノール 60.0 g
精製水にて全量 100 mL
Formulation examples are given below, but the present invention is not limited to these examples.
Formulation Example 1 (External hair restorer)
The following components were weighed and adjusted to 100 mL with purified water.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1500) 1.0 g
Resorcin 1.0 g
Pantothenyl ethyl ether 0.1 g
Propylene glycol 10.0 g
95% ethanol 60.0 g
100 mL total volume with purified water
製剤実施例2(外用育毛剤)
下記の各成分を秤量し、95%エタノールにて100mLに調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1000) 1.0 g
ヒノキチオール 0.05 g
酢酸トコフェロール 0.5 g
プロピレングリコール 10.0 g
95%エタノールにて全量 100 mL
Formulation Example 2 (External hair restorer)
The following components were weighed and adjusted to 100 mL with 95% ethanol.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1000) 1.0 g
Hinokitiol 0.05 g
Tocopherol acetate 0.5 g
Propylene glycol 10.0 g
製剤実施例3(外用育毛剤)
下記の各成分を秤量し、精製水にて100mLに調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1200) 1.0 g
ヒノキチオール 0.05 g
プロピレングリコール 10.0 g
95%エタノール 50.0 g
精製水にて全量 100 mL
Formulation Example 3 (External hair restorer)
The following components were weighed and adjusted to 100 mL with purified water.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1200) 1.0 g
Hinokitiol 0.05 g
Propylene glycol 10.0 g
95% ethanol 50.0 g
100 mL total volume with purified water
製剤実施例4(外用育毛剤)
下記の各成分を秤量し、精製水にて100mLに調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1800) 1.0 g
セファランチン 0.05 g
プロピレングリコール 10.0 g
95%エタノール 50.0 g
精製水にて全量 100 mL
Formulation Example 4 (External hair restorer)
The following components were weighed and adjusted to 100 mL with purified water.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1800) 1.0 g
Cephalanthin 0.05 g
Propylene glycol 10.0 g
95% ethanol 50.0 g
100 mL total volume with purified water
製剤実施例5(外用育毛剤)
下記の各成分を秤量し、精製水にて100mLに調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1500) 1.0 g
L−メントール 0.01 g
プロピレングリコール 10.0 g
95%エタノール 60.0 g
精製水にて全量 100 mL
Formulation Example 5 (External hair restorer)
The following components were weighed and adjusted to 100 mL with purified water.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1500) 1.0 g
L-Menthol 0.01 g
Propylene glycol 10.0 g
95% ethanol 60.0 g
100 mL total volume with purified water
製剤実施例6(外用育毛剤)
下記の各成分を秤量し、精製水にて100mLに調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約2000) 1.0 g
塩酸ピリドキシン 5.0 mg
パントテニルエチルエーテル 0.1 g
プロピレングリコール 10.0 g
95%エタノール 60.0 g
精製水にて全量 100 mL
Formulation Example 6 (External hair restorer)
The following components were weighed and adjusted to 100 mL with purified water.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 2000) 1.0 g
Pyridoxine hydrochloride 5.0 mg
Pantothenyl ethyl ether 0.1 g
Propylene glycol 10.0 g
95% ethanol 60.0 g
100 mL total volume with purified water
製剤実施例7(外用育毛剤)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1800) 1.0 g
カルボキシビニルポリマー 0.1 g
エデト酸ナトリウム水和物 0.05 g
ポリビニルアルコール 1.0 g
トリエタノールアミン 0.5 g
精製水 54.75 g
(以上、水相成分)
l−メントール 1.0 g
酢酸トコフェロール 0.1 g
エタノール 40.0 g
ポリソルベート80 0.6 g
プロピレングリコール 0.2 g
エトキシジグリコール 0.5 g
リン脂質 0.1 g
(以上、油相成分)
全量 100 g
Formulation Example 7 (External hair restorer)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1800) 1.0 g
Carboxyvinyl polymer 0.1 g
Edetate sodium hydrate 0.05 g
Polyvinyl alcohol 1.0 g
Triethanolamine 0.5 g
Purified water 54.75 g
(End of water phase component)
l-Menthol 1.0 g
Tocopherol acetate 0.1 g
Ethanol 40.0 g
Polysorbate 80 0.6 g
Propylene glycol 0.2 g
Ethoxydiglycol 0.5 g
Phospholipid 0.1 g
(End of oil phase component)
100 g total
製剤実施例8(外用育毛剤)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1500) 1.0 g
カルボキシビニルポリマー 0.4 g
フコイダン 0.5 g
エデト酸ナトリウム水和物 0.05 g
ポリビニルアルコール 0.3 g
トリエタノールアミン 1.0 g
精製水 53.15 g
(以上、水相成分)
l−メントール 2.0 g
酢酸トコフェロール 0.1 g
エタノール 40.0 g
ポリソルベート80 0.6 g
プロピレングリコール 0.2 g
エトキシジグリコール 0.5 g
リン脂質 0.1 g
(以上、油相成分)
全量 100 g
Formulation Example 8 (External hair restorer)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1500) 1.0 g
Carboxyvinyl polymer 0.4 g
Fucoidan 0.5 g
Edetate sodium hydrate 0.05 g
Polyvinyl alcohol 0.3 g
Triethanolamine 1.0 g
Purified water 53.15 g
(End of water phase component)
l-Menthol 2.0 g
Tocopherol acetate 0.1 g
Ethanol 40.0 g
Polysorbate 80 0.6 g
Propylene glycol 0.2 g
Ethoxydiglycol 0.5 g
Phospholipid 0.1 g
(End of oil phase component)
100 g total
製剤実施例9(シャンプー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.5 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1800) 1.0 g
N−ココイルメチルタウリンナトリウム(30%水溶液) 10.0 g
POE(2)ラウリルエーテル硫酸ナトリウム(27%水溶液) 20.0 g
ラウリルジメチルアミノ硫酸ベタイン(35%水溶液) 10.0 g
ヤシ油脂肪酸ジエタノールアミド 4.0 g
ジプロピレングリコール 2.0 g
クエン酸 0.1 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 9 (Shampoo)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.5 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1800) 1.0 g
N-cocoyl methyl taurine sodium (30% aqueous solution) 10.0 g
POE (2) sodium lauryl ether sulfate (27% aqueous solution) 20.0 g
Lauryldimethylaminosulfate betaine (35% aqueous solution) 10.0 g
Palm oil fatty acid diethanolamide 4.0 g
Dipropylene glycol 2.0 g
Citric acid 0.1 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例10(シャンプー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約2000) 0.5 g
テトラデセンスルホン酸ナトリウム 10.0 g
N−アシル−L−グルタミン酸トリエタノールアミン(30%水溶液) 5.0 g
N−アシル−メチルアラニンナトリウム(30%水溶液) 5.0 g
ヤシ油脂肪酸ジエタノールアミド 1.0 g
トリメチルグリシン 1.0 g
ジステアリン酸PEG−190 0.5 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 10 (Shampoo)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Soy protein thermolysin degradation product (peak average molecular weight about 2000) 0.5 g
Sodium tetradecenesulfonate 10.0 g
N-acyl-L-glutamic acid triethanolamine (30% aqueous solution) 5.0 g
Sodium N-acyl-methylalanine (30% aqueous solution) 5.0 g
Coconut oil fatty acid diethanolamide 1.0 g
Trimethylglycine 1.0 g
PEG-190 distearic acid 0.5 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例11(シャンプー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1500) 1.0 g
POE(2)ラウリルエーテル硫酸ナトリウム(27%水溶液) 10.0 g
ラウリン酸アミドプロピルベタイン(30%水溶液) 15.0 g
N−アシル−L−グルタミン酸トリエタノールアミン(30%水溶液) 5.0 g
1,3−ブチレングリコール 3.0 g
ジステアリン酸グリコール 2.0 g
ポリクオタニウム−10 0.2 g
水添レシチン 0.2 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 11 (Shampoo)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1500) 1.0 g
POE (2) sodium lauryl ether sulfate (27% aqueous solution) 10.0 g
Lauric acid amidopropyl betaine (30% aqueous solution) 15.0 g
N-acyl-L-glutamic acid triethanolamine (30% aqueous solution) 5.0 g
1,3-butylene glycol 3.0 g
Glycol distearate 2.0 g
Polyquaternium-10 0.2 g
Hydrogenated lecithin 0.2 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例12(ヘアコンディショナー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.5 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1800) 0.5 g
ジンクピリチオン 0.01 g
メチルフェニルポリシロキサン 1.0 g
ジメチルポリシロキサン 3.0 g
硬化ナタネ油アルコール 2.0 g
ミリスチン酸イソプロピル 2.0 g
プロピレングリコール 3.0 g
(アジピン酸・2エチルヘキサン酸・ステアリン酸)グリセリル 2.0 g
塩化ジステアリルジメチルアンモニウム 0.5 g
セタノール 1.0 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 12 (hair conditioner)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.5 g
Soy protein thermolysin degradation product (peak average molecular weight about 1800) 0.5 g
Zinc pyrithione 0.01 g
Methylphenylpolysiloxane 1.0 g
Dimethylpolysiloxane 3.0 g
Hardened rapeseed oil alcohol 2.0 g
Isopropyl myristate 2.0 g
Propylene glycol 3.0 g
(Adipic acid, 2-ethylhexanoic acid, stearic acid) Glyceryl 2.0 g
Distearyldimethylammonium chloride 0.5 g
Cetanol 1.0 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例13(ヘアコンディショナー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.5 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1500) 1.0 g
グリチルリチン酸ジカリウム 0.1 g
シクロペンタシロキサン 3.0 g
ステアリルアルコール 2.0 g
パルミチン酸エチルヘキシル 2.0 g
ジプロピレングリコール 3.0 g
トリエチルヘキサン酸グリセリル 2.5 g
セタノール 1.0 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 13 (hair conditioner)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.5 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1500) 1.0 g
Dipotassium glycyrrhizinate 0.1 g
Cyclopentasiloxane 3.0 g
Stearyl alcohol 2.0 g
Ethylhexyl palmitate 2.0 g
Dipropylene glycol 3.0 g
Glyceryl triethylhexanoate 2.5 g
Cetanol 1.0 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例14(ヘアコンディショナー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約2000) 1.0 g
ジメチルポリシロキサン 3.0 g
セチルアルコール 1.5 g
ステアリルアルコール 1.0 g
グリセリン 3.0 g
流動パラフィン 1.0 g
塩化ステアリルトリメチルアンモニウム 0.7 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 14 (hair conditioner)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 2000) 1.0 g
Dimethylpolysiloxane 3.0 g
Cetyl alcohol 1.5 g
Stearyl alcohol 1.0 g
Glycerin 3.0 g
Liquid paraffin 1.0 g
Stearyltrimethylammonium chloride 0.7 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例15(ヘアコンディショナー)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.5 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1200) 2.0 g
ジメチルポリシロキサン 2.0 g
ステアリルアルコール 1.5 g
ベヘニルアルコール 0.5 g
プロピレングリコール 3.0 g
塩化ベヘニルトリメチルアンモニウム 2.0 g
塩化ジステアリルジメチルアンモニウム 1.0 g
ヒドロキシエチルセルロース 0.3 g
セタノール 2.0 g
メチルパラベン 0.2 g
精製水にて全量 100 mL
Formulation Example 15 (hair conditioner)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.5 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1200) 2.0 g
Dimethylpolysiloxane 2.0 g
Stearyl alcohol 1.5 g
Behenyl alcohol 0.5 g
Propylene glycol 3.0 g
Behenyltrimethylammonium chloride 2.0 g
Distearyldimethylammonium chloride 1.0 g
Hydroxyethylcellulose 0.3 g
Cetanol 2.0 g
Methylparaben 0.2 g
100 mL total volume with purified water
製剤実施例16(頭皮用ローション)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約2000) 1.0 g
ステアリン酸グリセリル 1.0 g
ステアリン酸PEG−5グリセリル 1.0 g
ポリエーテル変性シリコーン 0.4 g
ステアリン酸K 0.4 g
べへニルアルコール 0.4 g
スクワラン 2.0 g
エチルヘキサン酸セチル 2.0 g
1,3−ブチレングリコール 10.0 g
グリセリン 5.0 g
カルボマー(カーボポールETD2050) 0.1 g
ポリビニルアルコール 0.3 g
メチルパラベン 0.2 g
精製水にて全量 100 g
Formulation Example 16 (Scalp lotion)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 2000) 1.0 g
Glyceryl stearate 1.0 g
PEG-5 glyceryl stearate 1.0 g
Polyether-modified silicone 0.4 g
Stearic acid K 0.4 g
Behenyl alcohol 0.4 g
Squalane 2.0 g
Cetyl ethylhexanoate 2.0 g
1,3-butylene glycol 10.0 g
Glycerin 5.0 g
Carbomer (Carbopol ETD2050) 0.1 g
Polyvinyl alcohol 0.3 g
Methylparaben 0.2 g
100 g in purified water
製剤実施例17(頭皮用クリーム)
下記の各成分を秤量し、常法に従って調製した。
グリチルリチン酸ジカリウム 0.1 g
ダイズタンパク質のサーモリシン分解物(ピーク平均分子量約1500) 1.0 g
ステアリン酸PEG−40 2.0 g
モノステアリン酸グリセリル(自己乳化型) 5.0 g
MCステアリン酸 5.0 g
ベヘニルアルコール 0.5 g
スクワラン 15.0 g
イソオクタン酸セチル 5.0 g
メチルパラベン 0.1 g
ブチルパラベン 0.1 g
1,3−ブチレングリコール 5.0 g
精製水にて全量 100 g
Formulation Example 17 (Scalp Cream)
The following components were weighed and prepared according to a conventional method.
Dipotassium glycyrrhizinate 0.1 g
Thermolysin degradation product of soybean protein (peak average molecular weight about 1500) 1.0 g
PEG-40 stearic acid 2.0 g
Glyceryl monostearate (self-emulsifying) 5.0 g
MC stearic acid 5.0 g
Behenyl alcohol 0.5 g
Squalane 15.0 g
Cetyl isooctanoate 5.0 g
Methylparaben 0.1 g
Butylparaben 0.1 g
1,3-butylene glycol 5.0 g
100 g in purified water
以上のように、本発明の好ましい実施形態を用いて本発明を説明した。しかし、本願発明の範囲は、添付の特許請求の範囲の記載によっての解釈されるべきであることは容易に理解されることである。本明細書において引用した特許、特許出願および文献は、それらの内容が具体的に本明細書に記載されているのと同様に、その内容が本明細書中に参考として援用されるべきであることは、理解されるであろう。 As described above, the present invention has been described using the preferred embodiments of the present invention. However, it should be readily understood that the scope of the present invention should be construed in accordance with the description of the appended claims. The patents, patent applications and literature cited herein are to be incorporated herein by reference in the same way that their contents are specifically described herein. That will be understood.
本発明の育毛剤は、ダイズタンパク質のサーモリシン分解物又はダイズタンパク質のサーモリシン様プロテアーゼ分解物を配合することにより、グリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩の育毛効果が増強された、育毛効果と安全性が高い育毛剤である為に、工業的利用価値が高い。 The hair-growth agent of the present invention has enhanced the hair-growth effect of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof by blending a thermolysin degradation product of soybean protein or a thermolysin-like protease degradation product of soybean protein, Since it is a hair-growth agent with high hair-growth effect and safety, it has high industrial utility value.
Claims (9)
(A)グリチルリチン酸、グリチルレチン酸、これらの誘導体、及びこれらの塩からなる群より選択される1種又は2種以上、並びに
(B)ダイズタンパク質のサーモリシン分解物又はダイズタンパク質のサーモリシン様プロテアーゼ分解物であって、サーモリシン分解物と同等の育毛活性を有する産物
を含有する育毛剤。 The following ingredients:
(A) One or more selected from the group consisting of glycyrrhizic acid, glycyrrhetinic acid, derivatives thereof, and salts thereof, and (B) a thermolysin degradation product of soybean protein or a thermolysin-like protease degradation product of soybean protein A hair restorer containing a product having hair growth activity equivalent to that of a thermolysin degradation product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008132033A JP5216414B2 (en) | 2007-10-11 | 2008-05-20 | Hair restorer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007265522 | 2007-10-11 | ||
JP2007265522 | 2007-10-11 | ||
JP2008132033A JP5216414B2 (en) | 2007-10-11 | 2008-05-20 | Hair restorer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009108023A true JP2009108023A (en) | 2009-05-21 |
JP5216414B2 JP5216414B2 (en) | 2013-06-19 |
Family
ID=40776935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008132033A Expired - Fee Related JP5216414B2 (en) | 2007-10-11 | 2008-05-20 | Hair restorer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5216414B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014186244A1 (en) * | 2013-05-16 | 2014-11-20 | The Procter & Gamble Company | Hair thickening compositions and methods of use |
WO2020004200A1 (en) * | 2018-06-29 | 2020-01-02 | 小林製薬株式会社 | COMPOSITION INCLUDING D-chiro-INOSITOL |
WO2020004201A1 (en) * | 2018-06-29 | 2020-01-02 | 小林製薬株式会社 | COMPOSITION INCLUDING D-chiro-INOSITOL |
WO2020004202A1 (en) * | 2018-06-29 | 2020-01-02 | 小林製薬株式会社 | COMPOSITION INCLUDING D-chiro-INOSITOL |
JP2021130620A (en) * | 2020-02-19 | 2021-09-09 | 大正製薬株式会社 | Keratinocyte growth promoter and hair growth-related factor regulator |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05279228A (en) * | 1992-03-31 | 1993-10-26 | Kanebo Ltd | Hair tonic |
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
JPH09249535A (en) * | 1996-03-13 | 1997-09-22 | Honen Corp | Anti-alopecic agent |
JP2007302655A (en) * | 2006-04-13 | 2007-11-22 | Rohto Pharmaceut Co Ltd | Hair restorer |
-
2008
- 2008-05-20 JP JP2008132033A patent/JP5216414B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05279228A (en) * | 1992-03-31 | 1993-10-26 | Kanebo Ltd | Hair tonic |
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
JPH09249535A (en) * | 1996-03-13 | 1997-09-22 | Honen Corp | Anti-alopecic agent |
JP2007302655A (en) * | 2006-04-13 | 2007-11-22 | Rohto Pharmaceut Co Ltd | Hair restorer |
Non-Patent Citations (2)
Title |
---|
TSURUKI,T. ET AL: "Anti-alopecia mechanisms of soymetide-4, an immunostimulating peptide derived from soy beta-conglyci", PEPTIDES, vol. 26, no. 5, JPN6012060238, 2005, pages 707 - 11, ISSN: 0002387292 * |
日本農芸化学会誌, vol. 75, JPN7012004721, 2001, pages 191, ISSN: 0002387291 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014186244A1 (en) * | 2013-05-16 | 2014-11-20 | The Procter & Gamble Company | Hair thickening compositions and methods of use |
WO2020004200A1 (en) * | 2018-06-29 | 2020-01-02 | 小林製薬株式会社 | COMPOSITION INCLUDING D-chiro-INOSITOL |
WO2020004201A1 (en) * | 2018-06-29 | 2020-01-02 | 小林製薬株式会社 | COMPOSITION INCLUDING D-chiro-INOSITOL |
WO2020004202A1 (en) * | 2018-06-29 | 2020-01-02 | 小林製薬株式会社 | COMPOSITION INCLUDING D-chiro-INOSITOL |
JP2020002105A (en) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | Composition comprising D-chiro-inositol |
JP2020002107A (en) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | Composition containing d-chiro-inositol |
JP2020002106A (en) * | 2018-06-29 | 2020-01-09 | 小林製薬株式会社 | Composition containing d-chiro-inositol |
JP7203522B2 (en) | 2018-06-29 | 2023-01-13 | 小林製薬株式会社 | Compositions containing D-chiro-inositol |
JP7519753B2 (en) | 2018-06-29 | 2024-07-22 | 小林製薬株式会社 | Compositions containing D-chiro-inositol |
JP7580183B2 (en) | 2018-06-29 | 2024-11-11 | 小林製薬株式会社 | Compositions containing D-chiro-inositol |
JP2021130620A (en) * | 2020-02-19 | 2021-09-09 | 大正製薬株式会社 | Keratinocyte growth promoter and hair growth-related factor regulator |
JP7578900B2 (en) | 2020-02-19 | 2024-11-07 | 大正製薬株式会社 | Keratinocyte proliferation promoter and hair growth-related factor regulator |
Also Published As
Publication number | Publication date |
---|---|
JP5216414B2 (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH08502509A (en) | Cosmetic composition | |
KR20130032788A (en) | Peptides for promotion of hair growth and the use thereof | |
EP2431031A2 (en) | Composition for preventing hair loss or for stimulating hair growth | |
JP5216414B2 (en) | Hair restorer | |
JP3597210B2 (en) | Hair restoration | |
JP5166116B2 (en) | Hair restorer | |
JP7135106B2 (en) | Scalp and hair composition | |
CN108367045B (en) | new use | |
CN111315387A (en) | Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth | |
JP2009091325A (en) | Hair growth agent | |
JP2005047910A (en) | Sebum secretion-inhibiting composition | |
JP2024163312A (en) | Composition for promoting hair growth | |
JP2012206966A (en) | Collagen originated in marine organism containing iii type collagen, and derivative thereof | |
JP4032246B2 (en) | White hair prevention and improvement agent | |
KR102386651B1 (en) | Composition for preventing or treating hair loss comprising tiplaxtinin | |
KR102147604B1 (en) | Composition comprising sodium surfactin for inhibiting hair loss and promoting hair growth | |
JP2001139436A (en) | Hair tonic and grower | |
JP2006265120A (en) | Collagen synthesis promoter | |
US10406086B2 (en) | Moisturizer and cosmetic including the same | |
WO2020004580A1 (en) | Body odor production-preventing agent containing lactic acid bacterium | |
KR101113806B1 (en) | A composition for preventing or treating alopecia comprising L-threonate | |
JP2008280325A (en) | Skin external preparation, hair growth or hair growth agent, and lip external preparation | |
JP2020138932A (en) | Agents for promoting abca12 gene expression | |
EP4344696A1 (en) | Functional composition for alopecia comprising centipeda minima-derived extract | |
JP2004352634A (en) | Cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110328 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130108 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130226 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130304 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160308 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |